<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36851724</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>01</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>10</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1999-4915</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Feb</Month><Day>12</Day></PubDate></JournalIssue><Title>Viruses</Title><ISOAbbreviation>Viruses</ISOAbbreviation></Journal><ArticleTitle>Coxsackievirus A6 Infection Causes Neurogenic Pathogenesis in a Neonatal Murine Model.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">511</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/v15020511</ELocationID><Abstract><AbstractText>Coxsackievirus A6 (CVA6), a member of species A enterovirus, is associated with outbreaks of hand-foot-and-mouth disease and causes a large nationwide burden of disease. However, the molecular pathogenesis of CVA6 remains unclear. In the present study, we established a suckling Institute of Cancer Research (ICR) mouse infection model to explore the neural pathogenicity of CVA6. Five-day-old mice infected with CVA6 strain F219 showed lethargy and paralysis, and died 5 or 6 days after infection via IM injection. Cerebral edema and neuronal cell swelling were observed in the infected brain tissue, and we found that the CVA6 VP1 antigen could co-localize with GFAP-positive astrocytes in infected mouse brain using an immunofluorescence assay. CVA6 strain F219 can also infect human glioma (U251) cells. Transcriptome analysis of brain tissues from infected mice and infected U251 cells showed that significantly differentially expressed genes were enriched in antiviral and immune response and neurological system processes. These results indicate that CVA6 could cause neural pathogenesis and provide basic data for exploring the mechanism of how host-cell interactions affect viral replication and pathogenesis. Importance: Coxsackievirus A6 (CVA6) surpasses the two main pathogens, enterovirus 71 (EV-A71) and coxsackievirus A16 (CVA16), which are the leading pathogens causing HFMD in many provinces of China. In our study, CVA6 infection caused neurogenic pathogenesis in a neonatal murine model, manifesting as cerebral edema and neuronal cell swelling, CVA6 VP1 antigen could co-localize with GFAP-positive astrocytes in the infected mouse brain. Based on CVA6-infected brain tissue and U251 cell transcriptome analysis, we found upregulated antiviral and immune response-related genes such as Zbp1, Usp18, Oas2, Irf7, Ddx60, Ifit3, Ddx58, and Isg15, while the neurological system process-related genes were downregulated, including Fcrls, Ebnrb, Cdk1, and Anxa5.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Qiang</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>WHO WPRO Regional Polio Reference Laboratory, National Health Commission Key Laboratory for Biosafety, National Health Commission Key Laboratory for Medical Virology, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, 155 Changbai Road, Beijing 102206, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Jichen</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>WHO WPRO Regional Polio Reference Laboratory, National Health Commission Key Laboratory for Biosafety, National Health Commission Key Laboratory for Medical Virology, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, 155 Changbai Road, Beijing 102206, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Rui</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>WHO WPRO Regional Polio Reference Laboratory, National Health Commission Key Laboratory for Biosafety, National Health Commission Key Laboratory for Medical Virology, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, 155 Changbai Road, Beijing 102206, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Tiantian</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>WHO WPRO Regional Polio Reference Laboratory, National Health Commission Key Laboratory for Biosafety, National Health Commission Key Laboratory for Medical Virology, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, 155 Changbai Road, Beijing 102206, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zong</LastName><ForeName>Yanjun</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>WHO WPRO Regional Polio Reference Laboratory, National Health Commission Key Laboratory for Biosafety, National Health Commission Key Laboratory for Medical Virology, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, 155 Changbai Road, Beijing 102206, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Congcong</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>WHO WPRO Regional Polio Reference Laboratory, National Health Commission Key Laboratory for Biosafety, National Health Commission Key Laboratory for Medical Virology, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, 155 Changbai Road, Beijing 102206, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Ying</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>WHO WPRO Regional Polio Reference Laboratory, National Health Commission Key Laboratory for Biosafety, National Health Commission Key Laboratory for Medical Virology, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, 155 Changbai Road, Beijing 102206, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xiaoliang</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>WHO WPRO Regional Polio Reference Laboratory, National Health Commission Key Laboratory for Biosafety, National Health Commission Key Laboratory for Medical Virology, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, 155 Changbai Road, Beijing 102206, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Yang</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-7053-3836</Identifier><AffiliationInfo><Affiliation>WHO WPRO Regional Polio Reference Laboratory, National Health Commission Key Laboratory for Biosafety, National Health Commission Key Laboratory for Medical Virology, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, 155 Changbai Road, Beijing 102206, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yong</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-2692-5437</Identifier><AffiliationInfo><Affiliation>WHO WPRO Regional Polio Reference Laboratory, National Health Commission Key Laboratory for Biosafety, National Health Commission Key Laboratory for Medical Virology, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, 155 Changbai Road, Beijing 102206, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan 430071, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Viruses</MedlineTA><NlmUniqueID>101509722</NlmUniqueID><ISSNLinking>1999-4915</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.19.12</RegistryNumber><NameOfSubstance UI="C485560">USP18 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.19.12</RegistryNumber><NameOfSubstance UI="D043222">Ubiquitin Thiolesterase</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C402632">Zbp1 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016601">RNA-Binding Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001929" MajorTopicYN="Y">Brain Edema</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006232" MajorTopicYN="Y">Hand, Foot and Mouth Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D043222" MajorTopicYN="N">Ubiquitin Thiolesterase</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016601" MajorTopicYN="N">RNA-Binding Proteins</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">RNA-Seq</Keyword><Keyword MajorTopicYN="N">animal model</Keyword><Keyword MajorTopicYN="N">coxsackievirus A6</Keyword><Keyword MajorTopicYN="N">pathogenesis</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>2</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>28</Day><Hour>1</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>2</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36851724</ArticleId><ArticleId IdType="pmc">PMC9960737</ArticleId><ArticleId IdType="doi">10.3390/v15020511</ArticleId><ArticleId IdType="pii">v15020511</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lefkowitz E.J., Dempsey D.M., Hendrickson R.C., Orton R.J., Siddell S.G., Smith D.B. Virus taxonomy: The database of the International Committee on Taxonomy of Viruses (ICTV) Nucleic Acids Res. 2018;46:D708&#x2013;D717. doi: 10.1093/nar/gkx932.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkx932</ArticleId><ArticleId IdType="pmc">PMC5753373</ArticleId><ArticleId IdType="pubmed">29040670</ArticleId></ArticleIdList></Reference><Reference><Citation>Song Y., Zhang Y., Han Z., Xu W., Xiao J., Wang X., Wang J., Yang J., Yu Q., Yu D., et al. Genetic recombination in fast-spreading coxsackievirus A6 variants: A potential role in evolution and pathogenicity. Virus Evol. 2020;6:veaa048. doi: 10.1093/ve/veaa048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ve/veaa048</ArticleId><ArticleId IdType="pmc">PMC8597624</ArticleId><ArticleId IdType="pubmed">34804589</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji T., Han T., Tan X., Zhu S., Yan D., Yang Q., Song Y., Cui A., Zhang Y., Mao N., et al. Surveillance, epidemiology, and pathogen spectrum of hand, foot, and mouth disease in mainland of China from 2008 to 2017. Biosaf. Health. 2019;1:32&#x2013;40. doi: 10.1016/j.bsheal.2019.02.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bsheal.2019.02.005</ArticleId></ArticleIdList></Reference><Reference><Citation>Hussain K., Chawla S., Muir D., Roberts N. Clinical manifestations of coxsackievirus A6 what a dermatologist needs to know. Int. J. Dermatol. 2022 doi: 10.1111/ijd.16478.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijd.16478</ArticleId><ArticleId IdType="pubmed">36325795</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Xiong T., Meng Y., Zhao R., Yu G., Liu J., Xiao J., Wang K., Wu T., Wei S., et al. Risk factors for severe hand, foot, and mouth disease infected with Coxsackievirus A6: A hospital-based case-control study. J. Med. Virol. 2020;92:3144&#x2013;3150. doi: 10.1002/jmv.26343.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26343</ArticleId><ArticleId IdType="pubmed">32706451</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang X., Li Y., Zhang C., Zhan W., Xie J., Hu S., Chai H., Liu P., Zhao H., Tang B., et al. Clinical features and phylogenetic analysis of severe hand-foot-and-mouth disease caused by Coxsackievirus A6. Infect. Genet. Evol. 2020;77:104054. doi: 10.1016/j.meegid.2019.104054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.meegid.2019.104054</ArticleId><ArticleId IdType="pubmed">31683008</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu S., Li H., Qiao P., Xu G., Zhao D., Lin X., Qin Y., Yu H., Zhang X., Zhang W., et al. Neonatal hand, foot, and mouth disease due to coxsackievirus A6 in Shanghai. BMC Pediatr. 2020;20:364. doi: 10.1186/s12887-020-02262-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12887-020-02262-y</ArticleId><ArticleId IdType="pmc">PMC7397588</ArticleId><ArticleId IdType="pubmed">32741368</ArticleId></ArticleIdList></Reference><Reference><Citation>Qian S.S., Wei Z.N., Jin W.P., Wu J., Zhou Y.P., Meng S.L., Guo J., Wang Z.J., Shen S. Efficacy of a coxsackievirus A6 vaccine candidate in an actively immunized mouse model. Emerg. Microbes Infect. 2021;10:763&#x2013;773. doi: 10.1080/22221751.2021.1906755.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2021.1906755</ArticleId><ArticleId IdType="pmc">PMC8079124</ArticleId><ArticleId IdType="pubmed">33739899</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang Z., Zhang Y., Lin H., Cheng Q., Lu X., Liu W., Zhou R., Zhong B., Tian X. A 10-Day-Old Murine Model of Coxsackievirus A6 Infection for the Evaluation of Vaccines and Antiviral Drugs. Front. Immunol. 2021;12:665197. doi: 10.3389/fimmu.2021.665197.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.665197</ArticleId><ArticleId IdType="pmc">PMC8155526</ArticleId><ArticleId IdType="pubmed">34054834</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z., Dong Z., Wei Q., Carr M.J., Li J., Ding S., Tong Y., Li D., Shi W. A Neonatal Murine Model of Coxsackievirus A6 Infection for Evaluation of Antiviral and Vaccine Efficacy. J. Virol. 2017;91:e02450&#x2013;e02467. doi: 10.1128/JVI.02450-16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02450-16</ArticleId><ArticleId IdType="pmc">PMC5391469</ArticleId><ArticleId IdType="pubmed">28250116</ArticleId></ArticleIdList></Reference><Reference><Citation>Li D., Sun T., Tao L., Ji W., Zhu P., Liang R., Zhang Y., Chen S., Yang H., Jin Y., et al. A mouse-adapted CVA6 strain exhibits neurotropism and triggers systemic manifestations in a novel murine model. Emerg. Microbes Infect. 2022;11:2248&#x2013;2263. doi: 10.1080/22221751.2022.2119166.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2022.2119166</ArticleId><ArticleId IdType="pmc">PMC9518251</ArticleId><ArticleId IdType="pubmed">36036059</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao T.S., Du J., Sun D.P., Zhu Q.R., Chen L.Y., Ye C., Wang S., Liu Y.Q., Cui F., Lu Q.B. A review and meta-analysis of the epidemiology and clinical presentation of coxsackievirus A6 causing hand-foot-mouth disease in China and global implications. Rev. Med. Virol. 2020;30:e2087. doi: 10.1002/rmv.2087.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2087</ArticleId><ArticleId IdType="pubmed">31811676</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S.H., Wang A., Liu P.P., Zhang W.Y., Du J., Xu S., Liu G.C., Zheng B.S., Huan C., Zhao K., et al. Divergent Pathogenic Properties of Circulating Coxsackievirus A6 Associated with Emerging Hand, Foot, and Mouth Disease. J. Virol. 2018;92:e00303&#x2013;e00318. doi: 10.1128/JVI.00303-18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00303-18</ArticleId><ArticleId IdType="pmc">PMC5952127</ArticleId><ArticleId IdType="pubmed">29563294</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen M., Zuo X., Tan Y., Ju Y., Bi F., Wang H., Chen M. Six amino acids of VP1 switch along with pandemic of CV-A6-associated HFMD in Guangxi, southern China, 2010&#x2013;2017. J. Infect. 2019;78:323&#x2013;337. doi: 10.1016/j.jinf.2019.02.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2019.02.002</ArticleId><ArticleId IdType="pubmed">30771363</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu L., Zhao H., Zhang Y., Wang J., Che Y., Dong C., Zhang X., Na R., Shi H., Jiang L., et al. Neonatal rhesus monkey is a potential animal model for studying pathogenesis of EV71 infection. Virology. 2011;412:91&#x2013;100. doi: 10.1016/j.virol.2010.12.058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2010.12.058</ArticleId><ArticleId IdType="pubmed">21262515</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagata N., Shimizu H., Ami Y., Tano Y., Harashima A., Suzaki Y., Sato Y., Miyamura T., Sata T., Iwasaki T. Pyramidal and extrapyramidal involvement in experimental infection of cynomolgus monkeys with enterovirus 71. J. Med. Virol. 2002;67:207&#x2013;216. doi: 10.1002/jmv.2209.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.2209</ArticleId><ArticleId IdType="pubmed">11992581</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S.Y., Lin T.L., Chen H.Y., Lin T.S. Early and rapid detection of enterovirus 71 infection by an IgM-capture ELISA. J. Virol. Methods. 2004;119:37&#x2013;43. doi: 10.1016/j.jviromet.2004.02.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jviromet.2004.02.017</ArticleId><ArticleId IdType="pubmed">15109819</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagata N., Iwasaki T., Ami Y., Tano Y., Harashima A., Suzaki Y., Sato Y., Hasegawa H., Sata T., Miyamura T., et al. Differential localization of neurons susceptible to enterovirus 71 and poliovirus type 1 in the central nervous system of cynomolgus monkeys after intravenous inoculation. J. Gen. Virol. 2004;85:2981&#x2013;2989. doi: 10.1099/vir.0.79883-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.79883-0</ArticleId><ArticleId IdType="pubmed">15448361</ArticleId></ArticleIdList></Reference><Reference><Citation>Matschke J., Lutgehetmann M., Hagel C., Sperhake J.P., Schroder A.S., Edler C., Mushumba H., Fitzek A., Allweiss L., Dandri M., et al. Neuropathology of patients with COVID-19 in Germany: A post-mortem case series. Lancet Neurol. 2020;19:919&#x2013;929. doi: 10.1016/S1474-4422(20)30308-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(20)30308-2</ArticleId><ArticleId IdType="pmc">PMC7535629</ArticleId><ArticleId IdType="pubmed">33031735</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang G., Li J., Sun Q., Zhang K., Xu W., Zhang Y., Wu G. Pathological Features of Echovirus-11-Associated Brain Damage in Mice Based on RNA-Seq Analysis. Viruses. 2021;13:2477. doi: 10.3390/v13122477.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13122477</ArticleId><ArticleId IdType="pmc">PMC8707869</ArticleId><ArticleId IdType="pubmed">34960747</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J., Zhang G., Sun Q., Zhang K., Lu H., Xiao J., Han Z., Zhao H., Xu W., Zhang Y., et al. Pathological Characteristics of Echovirus 30 Infection in a Mouse Model. J. Virol. 2022;96:e0012922. doi: 10.1128/jvi.00129-22.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.00129-22</ArticleId><ArticleId IdType="pmc">PMC9093115</ArticleId><ArticleId IdType="pubmed">35420443</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng M., Guo S., Fan S., Zeng X., Zhang Y., Liao Y., Wang J., Zhao T., Wang L., Che Y., et al. The Preferential Infection of Astrocytes by Enterovirus 71 Plays a Key Role in the Viral Neurogenic Pathogenesis. Front. Cell Infect. Microbiol. 2016;6:192. doi: 10.3389/fcimb.2016.00192.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2016.00192</ArticleId><ArticleId IdType="pmc">PMC5174126</ArticleId><ArticleId IdType="pubmed">28066727</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai R.H., Chow Y.H., Chung N.H., Chen T.C., Shie F.S., Juang J.L. Neurotropic EV71 causes encephalitis by engaging intracellular TLR9 to elicit neurotoxic IL12-p40-iNOS signaling. Cell Death Dis. 2022;13:328. doi: 10.1038/s41419-022-04771-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-022-04771-3</ArticleId><ArticleId IdType="pmc">PMC8995170</ArticleId><ArticleId IdType="pubmed">35399111</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Q., Li J., Zhang B., Wang R., Wang C., Li X., Liu Y., Zhang Y. Transcriptome sequencing analysis of echovirus 30 infection reveals its potential pathogenesis. Front. Microbiol. 2022;13:958385. doi: 10.3389/fmicb.2022.958385.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2022.958385</ArticleId><ArticleId IdType="pmc">PMC9486006</ArticleId><ArticleId IdType="pubmed">36147849</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Y., Yang Z., Wang S., Sun D., Zhong M., Wen M., Song J., Zhang Y. Comprehensive analysis of differential expression profiles via transcriptome sequencing in SH-SY5Y cells infected with CV-A16. PLoS ONE. 2020;15:e0241174. doi: 10.1371/journal.pone.0241174.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0241174</ArticleId><ArticleId IdType="pmc">PMC7647100</ArticleId><ArticleId IdType="pubmed">33156879</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Y., Xu Y., Huang Z., Deng Z., Fan J., Yang R., Ma H., Song J., Zhang Y. Transcriptome sequencing analysis of SH-SY5Y cells infected with EV71 reveals the potential neuropathic mechanisms. Virus Res. 2020;282:197945. doi: 10.1016/j.virusres.2020.197945.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2020.197945</ArticleId><ArticleId IdType="pubmed">32220619</ArticleId></ArticleIdList></Reference><Reference><Citation>Colombo E., Farina C. Astrocytes: Key Regulators of Neuroinflammation. Trends Immunol. 2016;37:608&#x2013;620. doi: 10.1016/j.it.2016.06.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2016.06.006</ArticleId><ArticleId IdType="pubmed">27443914</ArticleId></ArticleIdList></Reference><Reference><Citation>Molofsky A.V., Kelley K.W., Tsai H.H., Redmond S.A., Chang S.M., Madireddy L., Chan J.R., Baranzini S.E., Ullian E.M., Rowitch D.H. Astrocyte-encoded positional cues maintain sensorimotor circuit integrity. Nature. 2014;509:189&#x2013;194. doi: 10.1038/nature13161.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature13161</ArticleId><ArticleId IdType="pmc">PMC4057936</ArticleId><ArticleId IdType="pubmed">24776795</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo Z., Su R., Wang W., Liang Y., Zeng X., Shereen M.A., Bashir N., Zhang Q., Zhao L., Wu K., et al. EV71 infection induces neurodegeneration via activating TLR7 signaling and IL-6 production. PLoS Pathog. 2019;15:e1008142. doi: 10.1371/journal.ppat.1008142.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1008142</ArticleId><ArticleId IdType="pmc">PMC6932824</ArticleId><ArticleId IdType="pubmed">31730654</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Z., Ren L., Zhang L., Zhong J., Xiao Y., Jia Z., Guo L., Yang J., Wang C., Jiang S., et al. Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients. Cell Host Microbe. 2020;27:883&#x2013;890.e2. doi: 10.1016/j.chom.2020.04.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2020.04.017</ArticleId><ArticleId IdType="pmc">PMC7196896</ArticleId><ArticleId IdType="pubmed">32407669</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuriakose T., Zheng M., Neale G., Kanneganti T.D. IRF1 Is a Transcriptional Regulator of ZBP1 Promoting NLRP3 Inflammasome Activation and Cell Death during Influenza Virus Infection. J. Immunol. 2018;200:1489&#x2013;1495. doi: 10.4049/jimmunol.1701538.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1701538</ArticleId><ArticleId IdType="pmc">PMC6483084</ArticleId><ArticleId IdType="pubmed">29321274</ArticleId></ArticleIdList></Reference><Reference><Citation>Daniels B.P., Kofman S.B., Smith J.R., Norris G.T., Snyder A.G., Kolb J.P., Gao X., Locasale J.W., Martinez J., Gale M., Jr., et al. The Nucleotide Sensor ZBP1 and Kinase RIPK3 Induce the Enzyme IRG1 to Promote an Antiviral Metabolic State in Neurons. Immunity. 2019;50:64&#x2013;76.e4. doi: 10.1016/j.immuni.2018.11.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2018.11.017</ArticleId><ArticleId IdType="pmc">PMC6342485</ArticleId><ArticleId IdType="pubmed">30635240</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou J., Han L., Zhao Z., Liu H., Zhang L., Ma C., Yi F., Liu B., Zheng Y., Gao C. USP18 positively regulates innate antiviral immunity by promoting K63-linked polyubiquitination of MAVS. Nat. Commun. 2012;12:2970. doi: 10.1038/s41467-021-23219-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-23219-4</ArticleId><ArticleId IdType="pmc">PMC8137702</ArticleId><ArticleId IdType="pubmed">34016972</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh H., Koury J., Kaul M. Innate Immune Sensing of Viruses and Its Consequences for the Central Nervous System. Viruses. 2021;13:170. doi: 10.3390/v13020170.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13020170</ArticleId><ArticleId IdType="pmc">PMC7912342</ArticleId><ArticleId IdType="pubmed">33498715</ArticleId></ArticleIdList></Reference><Reference><Citation>VanBlargan L.A., Himansu S., Foreman B.M., Ebel G.D., Pierson T.C., Diamond M.S. An mRNA Vaccine Protects Mice against Multiple Tick-Transmitted Flavivirus Infections. Cell Rep. 2018;25:3382&#x2013;3392.e3. doi: 10.1016/j.celrep.2018.11.082.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2018.11.082</ArticleId><ArticleId IdType="pmc">PMC6353567</ArticleId><ArticleId IdType="pubmed">30566864</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>